TY - JOUR AU - Ivanova, L. A. PY - 2013/10/10 Y2 - 2024/03/29 TI - OPTIMIZATION OF GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND ACUTE CORONARY SYNDROME JF - Problems of Endocrine Pathology JA - PEP VL - 45 IS - 3 SE - DO - 10.21856/j-PEP.2013.3.04 UR - https://www.jpep.endocrinology.org.ua/index.php/1/article/view/529 SP - 30-39 AB - <p>These data suggest that careful control of blood glucose maintaining it within 4,4–7,8 mmol/l<br>in the acute phase of myocardial infarction and 10–11 mmol/l in the subacute stage associated with<br>relatively fewer complications of acute coronary syndrome in stationary phase of the treatment and<br>the best long-term prognosis. Using of oral preparations of sulfonylureas (gliclazide, glibenclamide)<br>doesn’t concede to insulin therapy influence on the incidence of complications and prognosis in patients<br>with type 2 diabetes complicated by the development of acute coronary syndrome with or without<br>elevation of the segment ST.</p> ER -